Serous Ovarian Cancer
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer (NCT05113368) | Sarah K. Lynam MD | 2022-06-28 |
| huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer (NCT05057715) | University of Pennsylvania | 2022-03-02 |
Track Serous Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.